Class,Axioms,Coverage
http://scai.fraunhofer.de/AlzheimerOntology#Clinical_interview_based_impression,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Enquiry_about_Diet_and_Nutrition,1,0.0004
http://scai.fraunhofer.de/NDDUO#Proportion,3,0.0012
http://scai.fraunhofer.de/AlzheimerOntology#Endothelium,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#IRS1,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Problems_recognizing_family_and_friends,1,0.0004
http://scai.fraunhofer.de/NDDUO#Rat,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#nortriptyline,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#neurotrophic_signalling,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Family_history,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Bapineuzumab,1,0.0004
http://scai.fraunhofer.de/NDDUO#Exposure,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#lipoic_acid,1,0.0004
http://scai.fraunhofer.de/NDDUO#Etiology,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Cerebospinal_fluid_biomarker,3,0.0012
http://scai.fraunhofer.de/AlzheimerOntology#Vesicular_recycling,1,0.0004
http://scai.fraunhofer.de/NDDUO#neurodegenerative_disease,9,0.0037
http://scai.fraunhofer.de/NDDUO#Gender,5,0.0021
http://scai.fraunhofer.de/AlzheimerOntology#apoE4_BBB_model,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#CDH2,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#amitriptyline,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Gingko_biloba,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Placebo_controlled_study,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#mirtazapine,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#catechin,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#placebo,1,0.0004
http://www.ifomis.org/bfo/1.1/snap#Continuant,12,0.0050
http://scai.fraunhofer.de/AlzheimerOntology#NMDA_receptor_antagonist_drug_molecule,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Symptoms_of_Mild_Cognitve_Impairment,4,0.0017
http://scai.fraunhofer.de/AlzheimerOntology#Amyloid_beta_42_peptide_and_tau_protein_corelation,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Nrf2,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Subtypes,12,0.0050
http://scai.fraunhofer.de/AlzheimerOntology#Nicotine_Consumtion,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#CDK5,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#trandolapril,2,0.0008
http://scai.fraunhofer.de/NDDUO#Intervention,3,0.0012
http://scai.fraunhofer.de/AlzheimerOntology#Physiological_symptoms_of_moderate_cognitive_decline,8,0.0033
http://scai.fraunhofer.de/AlzheimerOntology#aluminium,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Apptm1Cep,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#insulin_signalling,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#psychological_symptom,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#p_tau_p_tau_AB_42,3,0.0012
http://scai.fraunhofer.de/AlzheimerOntology#BAG1,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Difficulty_in_doing_tasks_involving_multiple_steps,1,0.0004
http://scai.fraunhofer.de/NDDUO#Cause_specific_mortality_rate,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#BAG2,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#NINCDS/ADRDA_criteria,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Red_blood_cell_count,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Dopaminergic_neuron,1,0.0004
http://scai.fraunhofer.de/NDDUO#Birth_defect_rate,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Metabolic_Markers,3,0.0012
http://scai.fraunhofer.de/AlzheimerOntology#zinc,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Endfeet,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#diencephalon,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Antipsychotic_drugs,36,0.0150
http://scai.fraunhofer.de/AlzheimerOntology#Symptoms_of_moderate_cognitive_decline,4,0.0017
http://scai.fraunhofer.de/AlzheimerOntology#Repeating_questions,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#cell_representing_cellular_and_subcellular_entities,14,0.0058
http://scai.fraunhofer.de/AlzheimerOntology#brainstem,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#antioxidant_therapy,2,0.0008
http://scai.fraunhofer.de/NDDUO#Clinical_treatment,5,0.0021
http://scai.fraunhofer.de/AlzheimerOntology#bmi,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#RNA,3,0.0012
http://scai.fraunhofer.de/AlzheimerOntology#Blood_test,16,0.0067
http://www.ifomis.org/bfo/1.1/snap#OneDimensionalRegion,5,0.0021
http://scai.fraunhofer.de/NDDUO#Pathogenesis,4,0.0017
http://scai.fraunhofer.de/AlzheimerOntology#case_report,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#SERPINI1,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#GLP1,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#survivor,2,0.0008
http://scai.fraunhofer.de/NDDUO#Sex_specific_mortality_rate,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Cell_treatment,1,0.0004
http://scai.fraunhofer.de/NDDUO#Crude_mortality_rate,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#suprofen,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#venlafaxine,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#De_acetylations,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Msr1tm1Csk,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Inability_to_communicate,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#C10AA_HMG_CoA_reductase_inhibitor_drug,3,0.0012
http://scai.fraunhofer.de/AlzheimerOntology#lipoprotein_receptor,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#ApoE_genotype_test,1,0.0004
http://www.ifomis.org/bfo/1.1/span#ProcessualContext,6,0.0025
http://scai.fraunhofer.de/AlzheimerOntology#Efferent,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Neurotoxin_model,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Noradrenergic,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#history_of_cerebo_vascular_disease,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Gilatide,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#SOS2,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#APC,2,0.0008
http://www.ifomis.org/bfo/1.1/span#FiatProcessPart,6,0.0025
http://scai.fraunhofer.de/AlzheimerOntology#amyloid_precursor_protein,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Klc1tm1Gsn,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#mixed_dementia,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#fluphenazine,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#noradrenaline,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Atorvastation,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Psen1tm1Tak,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#oxygen,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Simvastatin,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Ubiquitination,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#VPS35,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#quinapril,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Redirect_the_patient_s_attention,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Wide_Range_Achievement_Test,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#GCSF,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Extracellular_signal_related_kinase_2_phosphorylation,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#promazine,2,0.0008
http://scai.fraunhofer.de/NDDUO#in_vitro_context,3,0.0012
http://scai.fraunhofer.de/NDDUO#syndrome_context,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#BIN1,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#dityrosine,1,0.0004
http://scai.fraunhofer.de/NDDUO#antirheumatic_drug,21,0.0087
http://scai.fraunhofer.de/AlzheimerOntology#tau_phosphorylation,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Tramiprosate,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Symptoms_of_moderate_AD,7,0.0029
http://scai.fraunhofer.de/AlzheimerOntology#flurbiprofen,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Astrocytes,2,0.0008
http://scai.fraunhofer.de/NDDUO#In_vitro_models,5,0.0021
http://scai.fraunhofer.de/AlzheimerOntology#Olanzapine,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#loxapine,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#written_and_formed_consent,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Consortium_to_establish_a_registry_for_Alzheimer_s_Disease,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#serotonin,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#NR1H3,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Blessed_test,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#DKK1,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Alzheimers_disease_Anti-inflamatory_prevention_trial,2,0.0008
http://scai.fraunhofer.de/NDDUO#Age,4,0.0017
http://scai.fraunhofer.de/AlzheimerOntology#Aluminium_Exposure,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#combined_estrogen_plus_progestin_therapy,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#vitamin_B,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#vitamin_A,3,0.0012
http://scai.fraunhofer.de/AlzheimerOntology#drug_for_cholinesterase_inhibition,3,0.0012
http://scai.fraunhofer.de/AlzheimerOntology#Donepezil,3,0.0012
http://scai.fraunhofer.de/AlzheimerOntology#Aluminium_exposure,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Diagnostic_test,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#vitamin_E,3,0.0012
http://scai.fraunhofer.de/AlzheimerOntology#vitamin_C,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Growth_cone,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#alcohol,3,0.0012
http://scai.fraunhofer.de/AlzheimerOntology#Vision_test,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Serum_Glutamic_pyruvic_tranaminase_testing,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Apathy_evaluation,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#heat_shock_protein,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Neuron_neuron_interaction,5,0.0021
http://scai.fraunhofer.de/AlzheimerOntology#nitroxide,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Presence_of_alzheimer_disease_associated_Protein,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#open_label_trial_study_arm,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Outcome,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#AD8,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#JUNB,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#study_caregiver,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#JUND,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#ACE,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Acetylation,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#intercellular_adhesion_molecule-1,3,0.0012
http://scai.fraunhofer.de/AlzheimerOntology#protriptyline,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#DEMTEC,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Node_of_Ranvier,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Hippocampal_neuron_cell_culture,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#ADL,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#CDKN2A,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#SLC2A4,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Crude_incidence,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Microglia_cell_line_related_to_non_clinical_entity,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#C_EBP,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#secretase_inhibitor_drug_molecule,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#type_3_diabetes,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#calcium_signalling,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Neurological_Symptoms_of_Moderate_cognitive_decline,3,0.0012
http://scai.fraunhofer.de/AlzheimerOntology#plasma_cystatin_C,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Amyotrophic_lateral_sclerosis,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Tau_test,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Kidney_Failure,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#chlorpromazine,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Open_populations,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#phosphatidylinositol_signalling,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#stroke,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Past_Illness,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#APIP2,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#APIP1,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#celecoxib,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Memantine,3,0.0012
http://scai.fraunhofer.de/AlzheimerOntology#Global_test,4,0.0017
http://scai.fraunhofer.de/AlzheimerOntology#hypertension,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Imsomnia,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#NCSTN,4,0.0017
http://scai.fraunhofer.de/AlzheimerOntology#Transmitter_release,11,0.0046
http://scai.fraunhofer.de/AlzheimerOntology#mental_disorder,6,0.0025
http://scai.fraunhofer.de/AlzheimerOntology#PSENEN,2,0.0008
http://scai.fraunhofer.de/NDDUO#Monkey,3,0.0012
http://scai.fraunhofer.de/AlzheimerOntology#Mild_cognitive_Impairment,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Axonal_transport,1,0.0004
http://scai.fraunhofer.de/NDDUO#Clinical,6,0.0025
http://scai.fraunhofer.de/AlzheimerOntology#antioxidant_enzyme,3,0.0012
http://scai.fraunhofer.de/AlzheimerOntology#dentate_gyrus,1,0.0004
http://scai.fraunhofer.de/NDDUO#prevalence,9,0.0037
http://scai.fraunhofer.de/AlzheimerOntology#MS4A6E,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Apoetm3_APOE_4_Mae,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#CDKN1A,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Hearing_test,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Transforming_Growth_Factor_beta_,4,0.0017
http://scai.fraunhofer.de/AlzheimerOntology#Phosphorylation,3,0.0012
http://scai.fraunhofer.de/AlzheimerOntology#Dendrites,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Alph1,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Enviornmental_manipulations,2,0.0008
http://scai.fraunhofer.de/NDDUO#syndrome,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#stimulation_of_alpha_secretase,1,0.0004
http://scai.fraunhofer.de/NDDUO#Non_pharmacotherapy,8,0.0033
http://scai.fraunhofer.de/AlzheimerOntology#PRNP,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#phenylbutazone,3,0.0012
http://scai.fraunhofer.de/NDDUO#surgery_context,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#ADAM10,1,0.0004
http://scai.fraunhofer.de/NDDUO#Outcome,3,0.0012
http://scai.fraunhofer.de/AlzheimerOntology#PICALM,3,0.0012
http://scai.fraunhofer.de/AlzheimerOntology#l_tryptophan,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Perivascular_cells,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#brain_metabolism,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Unusual_Confusion,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#piroxicam,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Getting_lost,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Synaptic_uptake,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Plcb1tm1Hssh,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Huperine_A,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Enviornmental_causes,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Quetiapine,2,0.0008
http://scai.fraunhofer.de/NDDUO#C.elegans,4,0.0017
http://scai.fraunhofer.de/AlzheimerOntology#Drosophila_gene,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#WNT1,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#apoE3_BBB_model,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#reboxetine,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#MRS,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Astrocyte_associated_with_amyloid_beta_deposits,1,0.0004
http://www.ifomis.org/bfo/1.1/snap#ZeroDimensionalRegion,5,0.0021
http://scai.fraunhofer.de/AlzheimerOntology#Age_,1,0.0004
http://scai.fraunhofer.de/NDDUO#Clinical_trial,4,0.0017
http://scai.fraunhofer.de/NDDUO#biomarker,10,0.0042
http://scai.fraunhofer.de/AlzheimerOntology#tranylcypromine,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Problems_producing_people_s_names_or_the_right_words_for_objects_,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#drug_used_to_adjust_cholesterol_levels,4,0.0017
http://scai.fraunhofer.de/AlzheimerOntology#cholesterol_reducing_drug_side_effect,5,0.0021
http://www.ifomis.org/bfo/1.1/span#Process,33,0.0137
http://scai.fraunhofer.de/AlzheimerOntology#NUP54,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Discussion_and_self_Initiative,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#PK_11195,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#cholinergic_stress_reaction,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#NUP62,2,0.0008
http://scai.fraunhofer.de/NDDUO#Moderate,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Lewy_bodies,3,0.0012
http://scai.fraunhofer.de/AlzheimerOntology#IL8,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#IL6,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#PSEN1,4,0.0017
http://scai.fraunhofer.de/AlzheimerOntology#Protein_degradation,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#PCDH11X,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Physiological_Symptoms_of_Mild_Cognitve_Impairment,3,0.0012
http://scai.fraunhofer.de/AlzheimerOntology#secretase_gene,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#drug_used_against_depression,3,0.0012
http://scai.fraunhofer.de/AlzheimerOntology#dysmnesia_,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#HIV_testing,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#PSEN2,4,0.0017
http://scai.fraunhofer.de/NDDUO#Genetic_models,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Heartburn,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#cytoskeleton,1,0.0004
http://scai.fraunhofer.de/NDDUO#morbidity_context,3,0.0012
http://scai.fraunhofer.de/AlzheimerOntology#Modifying_the_home_enviornment_and_make_it_safer_for_the_patient,3,0.0012
http://scai.fraunhofer.de/AlzheimerOntology#FTLD_TDP_frontal_temporal_lobe,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#striatum,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#phosphatidic_acid,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#complement_component_C1q,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Bax_proteins,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Neutrophil,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#S100B,3,0.0012
http://scai.fraunhofer.de/AlzheimerOntology#SOD1,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Peptidergic,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#disease_onset,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Naproxen_Sodium,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#aplysia_neuron,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#NSAID_side_effect,7,0.0029
http://scai.fraunhofer.de/AlzheimerOntology#KCNIP3,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#MMP9,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Tarenflurbil,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Extracellular_matrix,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#GSK3B,4,0.0017
http://scai.fraunhofer.de/NDDUO#In_vivo_models,8,0.0033
http://www.ifomis.org/bfo/1.1/span#ConnectedSpatiotemporalRegion,6,0.0025
http://scai.fraunhofer.de/NDDUO#Analytical_study,3,0.0012
http://scai.fraunhofer.de/AlzheimerOntology#neurovascular_dysfunction,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Confusion,2,0.0008
http://scai.fraunhofer.de/NDDUO#Mortality,3,0.0012
http://scai.fraunhofer.de/AlzheimerOntology#GSK3A,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Problem_in_handling_financial_results_from_mathematical_challenges_,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#DYRK1A_phosphorylation,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#INS,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Depression_and_other_mood_disturbances_can_occur,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Groaning__moaning_or_grunting,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#fluoxetine,2,0.0008
http://scai.fraunhofer.de/NDDUO#pre_clinical_context,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#t_tau,3,0.0012
http://scai.fraunhofer.de/AlzheimerOntology#Potassium_transport,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Recent_events_and_conversations_are_increasingly_Forgotten_,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Adrenergic_neuron,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#GLB1,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#isocarboxazid,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#lovastatin,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Incidence,7,0.0029
http://scai.fraunhofer.de/AlzheimerOntology#Abeta_RAGE_interaction,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Factor_H,3,0.0012
http://scai.fraunhofer.de/AlzheimerOntology#process_for_locating_biomarker_image_based,5,0.0021
http://scai.fraunhofer.de/NDDUO#Study_type,14,0.0058
http://scai.fraunhofer.de/AlzheimerOntology#Side_effects_of_NSAID_s,3,0.0012
http://scai.fraunhofer.de/AlzheimerOntology#EGF,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#estrogen,1,0.0004
http://scai.fraunhofer.de/NDDUO#descriptive_statistical_context,19,0.0079
http://scai.fraunhofer.de/NDDUO#non_clinical_context,6,0.0025
http://scai.fraunhofer.de/AlzheimerOntology#pioglitazone,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#periventricular_grey_matter,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Single_photon_emission_computed_tomography,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Neurological_Symptoms_of_Mild_Cognitve_Impairment,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Guinea_pig,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Hsp70,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Rember,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Positron_emission_tomography,10,0.0042
http://scai.fraunhofer.de/AlzheimerOntology#White_blood_cell_count,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#docosahexaenoic_acid,2,0.0008
http://scai.fraunhofer.de/NDDUO#Screening,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Students_t_test,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Odds_ratio,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#presenilin_2,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#presenilin_1,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Clonazepam,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#MIF,1,0.0004
http://scai.fraunhofer.de/NDDUO#Invertebrate,3,0.0012
http://scai.fraunhofer.de/AlzheimerOntology#Neuron_neurin_interaction,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#sirtuin_1,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Impulsive_behavior,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Pulse_rate_checkup,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Tangles,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Primary_glial_cell_culture,4,0.0017
http://scai.fraunhofer.de/AlzheimerOntology#Adenosinergic_neuron,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Dendritic_spine,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#sleep_disorder,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#cortico_subcortical_region,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#participation_in_other_clinical_study_within_3_months,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Monocyte,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#cellular_and_subcellular_processes_related_to_astrocytes,4,0.0017
http://scai.fraunhofer.de/AlzheimerOntology#Gamma_secretase_inhibitor,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#TF,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Eventual_causes,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Schwann_cells,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#endothelial_dysfunction,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#NSAID_medication,2,0.0008
http://scai.fraunhofer.de/NDDUO#Ligand_gated,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#neuron_as_cellular_entity,18,0.0075
http://scai.fraunhofer.de/NDDUO#clinical_trial_context,27,0.0112
http://scai.fraunhofer.de/NDDUO#First_generation_migrant,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Neurites,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#A2M,2,0.0008
http://scai.fraunhofer.de/NDDUO#Race,6,0.0025
http://scai.fraunhofer.de/AlzheimerOntology#APOE_genotype,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Microglia,2,0.0008
http://scai.fraunhofer.de/NDDUO#in_vivo_context,5,0.0021
http://scai.fraunhofer.de/AlzheimerOntology#CCL2_,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#maprotiline,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#glial_cell,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#MIR128_1,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#IDE,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#production_blockers,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Rey_auditory_verbal_learning_test,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#CD45,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Epigenetics,6,0.0025
http://scai.fraunhofer.de/AlzheimerOntology#BACE1,3,0.0012
http://scai.fraunhofer.de/AlzheimerOntology#cerebellum,1,0.0004
http://scai.fraunhofer.de/NDDUO#drug,5,0.0021
http://scai.fraunhofer.de/AlzheimerOntology#cerivastatin,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#ADCS_ADL,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#CCR9,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Pareital_lobe,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#CCR8,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Lossing_things_or_misplacing_them,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Cerebospinal_Fluid,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#gluatione_peroxidase_1,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Nucleus,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#CCR1,2,0.0008
http://scai.fraunhofer.de/NDDUO#Cellular_and_sub_cellular_processes,7,0.0029
http://scai.fraunhofer.de/AlzheimerOntology#CD33,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#CCR3,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#CCR2,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Low_education_level,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Xiusanzhen,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#MME,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#CCR5,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#CCR4,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#CCR7,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#CD36,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#wnt_signalling,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#CCR6,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Psen1tm1Pcw,2,0.0008
http://scai.fraunhofer.de/NDDUO#Study_phase,7,0.0029
http://scai.fraunhofer.de/NDDUO#etiological_context,21,0.0087
http://scai.fraunhofer.de/AlzheimerOntology#preganglionic_cells,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#fibrinogen,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#perphenazine,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Serotonergic_neuron,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#proliferator_activated_receptor_gamma,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#arachidonic_acid,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#oxaprozin,2,0.0008
http://scai.fraunhofer.de/NDDUO#inhibitor,6,0.0025
http://scai.fraunhofer.de/AlzheimerOntology#Neurobehavioral_cognitive_status_examination,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#trifluoperazine,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#acetylcholinesterase_inhibitor,5,0.0021
http://scai.fraunhofer.de/AlzheimerOntology#Web_based_learning,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#B-Lymphocyte,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Purinergic,1,0.0004
http://scai.fraunhofer.de/NDDUO#toxic_cause_context,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#ptau181,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#neuroprotectin,2,0.0008
http://www.ifomis.org/bfo/1.1/span#TemporalRegion,7,0.0029
http://scai.fraunhofer.de/AlzheimerOntology#P38_mitogen_activated_protein_kinase,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#anterior_cingulate_cortex,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Lack_of_Vitality_,1,0.0004
http://scai.fraunhofer.de/NDDUO#Descriptive_statistics,3,0.0012
http://scai.fraunhofer.de/AlzheimerOntology#Psen1tm1Lpr,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Alzheimer_s_disease_assesment_scale_cognitive,1,0.0004
http://www.ifomis.org/bfo/1.1#Entity,6,0.0025
http://scai.fraunhofer.de/AlzheimerOntology#Mmetm1Cge,2,0.0008
http://scai.fraunhofer.de/NDDUO#Statistics,5,0.0021
http://scai.fraunhofer.de/AlzheimerOntology#cell_cycle_process,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#epigallocatechin_gallate,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Cuneus,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Methylation,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Trouble_handling_money_and_paying_bills,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Synaptic_transmission,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Lrp1tm2Her,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Sedation,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Dimebon,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#monoaminooxidase_B,1,0.0004
http://www.ifomis.org/bfo/1.1/snap#ObjectBoundary,7,0.0029
http://scai.fraunhofer.de/AlzheimerOntology#NINCDS_ADRDA_criterion,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Structural_Imaging,1,0.0004
http://scai.fraunhofer.de/NDDUO#Cell_cell_interaction,8,0.0033
http://www.ifomis.org/bfo/1.1/span#TemporalInterval,5,0.0021
http://scai.fraunhofer.de/AlzheimerOntology#Dizziness,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Reduced_memory_of_personal_history_,1,0.0004
http://scai.fraunhofer.de/NDDUO#Ex_vivo,3,0.0012
http://scai.fraunhofer.de/AlzheimerOntology#Protein_misfolding,1,0.0004
http://scai.fraunhofer.de/NDDUO#Standardized_mortality_rate,3,0.0012
http://scai.fraunhofer.de/AlzheimerOntology#duloxetine,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#inflammatory_enzyme,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#plasma_protein,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#glycogen_synthase_kinase_3_beta_phosphorylation,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#meloxicam,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#phenelzine,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Cytoskeleton,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#mefenamic_acid,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Cyclin_dependent_kinase_5_phosphorylation,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#cell_adhesion,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Toxic_screening,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#droperidol,2,0.0008
http://scai.fraunhofer.de/NDDUO#moderate_stage_context,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#acetophenazine,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#phytic_acid,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#MBP,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Dopaminergic,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#non_steroidal_drug_against_inflammation_and_rheuma,3,0.0012
http://scai.fraunhofer.de/AlzheimerOntology#Neuron_glia_interaction,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Ibuprofen,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#NIMH_dAD,2,0.0008
http://scai.fraunhofer.de/NDDUO#in_silico_context,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#amyloid_aggregator_drug_molecule,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#lesion,3,0.0012
http://scai.fraunhofer.de/AlzheimerOntology#Apoetm1Unc,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#cortical_thinning,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#diabetes,4,0.0017
http://scai.fraunhofer.de/AlzheimerOntology#Calcium_stores,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#cerebral_blood_flow,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#STUB1,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#_Montreal_Cognitive_Assessment_,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#diffusion_tensor_image,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#SORL1,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#cortex,11,0.0046
http://scai.fraunhofer.de/AlzheimerOntology#Membrane,1,0.0004
http://scai.fraunhofer.de/NDDUO#prevalence_context,10,0.0042
http://scai.fraunhofer.de/AlzheimerOntology#Nomo1,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#decursin_angelate,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#BACE1_inhibitor,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#LRP6,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#gamma_secretase_activity,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Hachinski_ischemia_scale_score,1,0.0004
http://scai.fraunhofer.de/NDDUO#thing_related_to_surgery,3,0.0012
http://scai.fraunhofer.de/AlzheimerOntology#Incidence_in_non_exposed,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#LRP1,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Problems_with_memory_or_concentration_,1,0.0004
http://scai.fraunhofer.de/NDDUO#population_based_study,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#limbic_lobe,1,0.0004
http://scai.fraunhofer.de/NDDUO#Symptoms,42,0.0175
http://scai.fraunhofer.de/AlzheimerOntology#Lysosomes,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#SKNMC,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Liver_Damage,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#peroxynitrite,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Screening_tests_for_syphlis_antibodies,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#perindopril,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Sumoylation,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#CCL2,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Electro_encophalogram,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Astrocyte_related_to_primary_glial_cell_culture,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#hippocampal_neuron,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#isoxsuprine,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#thing_that_can_increase_the_risk,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Synapse,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Granulocyte,4,0.0017
http://scai.fraunhofer.de/AlzheimerOntology#Blood,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#vitamin,7,0.0029
http://scai.fraunhofer.de/AlzheimerOntology#cathepsin_S,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#midlife_overweight,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Abeta_1-42_test,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#cytokine_based_inflammatory_marker,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Assesment_of_Anxiety_or_Depression,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#captopril,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#protein,36,0.0150
http://scai.fraunhofer.de/AlzheimerOntology#Everyday_Cognition_questionnaire,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#yellow,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#placebo_effect,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#RPS6KB1,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Energy_metabolism,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#differential_diagnosis,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Upregulation,1,0.0004
http://www.ifomis.org/bfo/1.1/snap#Disposition,5,0.0021
http://www.ifomis.org/bfo/1.1/span#SpatiotemporalInstant,3,0.0012
http://scai.fraunhofer.de/NDDUO#context,19,0.0079
http://scai.fraunhofer.de/AlzheimerOntology#Microglia_cell_line,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#antioxidant,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Beck_Depression_Inventory,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#cerebral_amyloid_angiopathy,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#C3,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Clinical_global_impression_of_change,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#entorhinal_cortex,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Person_time_incidence_rate,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#SNCA,4,0.0017
http://scai.fraunhofer.de/AlzheimerOntology#Lipid_metabolism,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#cardiometabolic_disorder,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Absolute_risk,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#NAbs_Abeta,1,0.0004
http://scai.fraunhofer.de/NDDUO#Mouse_,30,0.0125
http://scai.fraunhofer.de/NDDUO#Drosophila,9,0.0037
http://scai.fraunhofer.de/AlzheimerOntology#Mini_mental_state_exam,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Ptger2tm1Brey,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#current_depressive_episode,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Presence_of_Docosahexenoic_acid,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Idebenone,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#COX2,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Vesicular_transport,1,0.0004
http://scai.fraunhofer.de/NDDUO#Period_Prevalence,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#C10AA_HMG_CoA_reductase_inhibitor,9,0.0037
http://scai.fraunhofer.de/AlzheimerOntology#Oligodendrocyte_related_to_primary_glial_cell_culture,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#COX1,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Huntingtons_disease,1,0.0004
http://scai.fraunhofer.de/NDDUO#rate,6,0.0025
http://scai.fraunhofer.de/AlzheimerOntology#GROalpha,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#red,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Endocytosis,1,0.0004
http://scai.fraunhofer.de/NDDUO#Molecular_processes,26,0.0108
http://www.ifomis.org/bfo/1.1/snap#Function,7,0.0029
http://scai.fraunhofer.de/AlzheimerOntology#conformed_diagnosis_of_probable_AD,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#amygdala_region,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#GSTO1,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Indomethacin,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#MED12,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#MMP10,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Phosphatidyl_Serine,1,0.0004
http://www.ifomis.org/bfo/1.1/snap#SpatialRegion,12,0.0050
http://scai.fraunhofer.de/AlzheimerOntology#inferior_temporal_lobe,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#double_masked_study,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Etanercept,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Difficulty_in_learning_new_things,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Seizures,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#KCND3,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#KCND1,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#citalopram,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Side_effects_of_cholestrol_reducing_drugs,3,0.0012
http://scai.fraunhofer.de/AlzheimerOntology#Neurite_growth,1,0.0004
http://scai.fraunhofer.de/NDDUO#add_on_treatment_context,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#HTT,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Dyspraxia,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#NMDA_antagonist,3,0.0012
http://scai.fraunhofer.de/AlzheimerOntology#Afferent,1,0.0004
http://scai.fraunhofer.de/NDDUO#Standardized_mortality_ratio,1,0.0004
http://scai.fraunhofer.de/NDDUO#Age_period_cohort_analysis,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#neuronal_damage,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Ratio_abeta_42_abeta_40_test,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#NTproBNP,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Thioridazine,2,0.0008
http://scai.fraunhofer.de/NDDUO#Sampling,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#cc_chemokine_receptor_2_deficiency,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Presence_of_Preselin_Protein,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#PPARG,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Beta_amyloid_Mutant_Alzheimer_s_disease,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#vitamin_B6,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Neuropsychiatric_symptoms,1,0.0004
http://scai.fraunhofer.de/NDDUO#Stages,5,0.0021
http://scai.fraunhofer.de/AlzheimerOntology#incapability_of_swallowing_whole_oral_medicine,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#medial_temporal_lobe,1,0.0004
http://scai.fraunhofer.de/NDDUO#Descriptive_epidemiology,4,0.0017
http://scai.fraunhofer.de/NDDUO#In_vitro,3,0.0012
http://scai.fraunhofer.de/NDDUO#Diagnosis,4,0.0017
http://scai.fraunhofer.de/AlzheimerOntology#mutation,3,0.0012
http://scai.fraunhofer.de/NDDUO#molecular_context,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#cerebellar_cortex,2,0.0008
http://scai.fraunhofer.de/NDDUO#Point_prevalence,2,0.0008
http://scai.fraunhofer.de/NDDUO#Retrospective_cohort_study,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#liraglutide,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Beta_secretase,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Peripheral_blood_mononuclear_cells_DNA_,3,0.0012
http://scai.fraunhofer.de/AlzheimerOntology#Glycosylation,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Taking_longer_then_before_to_complete_normal_daily_tasks,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Axons,3,0.0012
http://scai.fraunhofer.de/AlzheimerOntology#NO_synthethase_inhibitor,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#ObsoleteClass,50,0.0208
http://scai.fraunhofer.de/AlzheimerOntology#Eosinophil,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#allicin,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#FTLD_TDP_temporal_lobe,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#rosuvastatin,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Enquiry_about_Usage_of_Tabacco_and_Alchohal,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Cerebospinal_fluid_test,12,0.0050
http://scai.fraunhofer.de/NDDUO#Migrant_study,3,0.0012
http://scai.fraunhofer.de/AlzheimerOntology#Complementry_health_approaches,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#neuron_related_to_cellular_and_sub_cellular_processes,1,0.0004
http://scai.fraunhofer.de/NDDUO#drug_role,19,0.0079
http://scai.fraunhofer.de/AlzheimerOntology#Head_Injury,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#performing_physical_activity,3,0.0012
http://scai.fraunhofer.de/AlzheimerOntology#midlife_obesity,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Drowziness,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Mini_cog,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#nucleus_accumbens,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Toxic_causes,5,0.0021
http://scai.fraunhofer.de/AlzheimerOntology#Post_translational_modification,6,0.0025
http://scai.fraunhofer.de/AlzheimerOntology#glucosamine,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#THOP1,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#metabolic_change,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Tauph,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#nefazodone,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#cholinesterase_inhibitor_side_effect,13,0.0054
http://scai.fraunhofer.de/NDDUO#clinical_treatment_context,7,0.0029
http://scai.fraunhofer.de/AlzheimerOntology#DAD,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Alpha2_Macroglobulin_,3,0.0012
http://scai.fraunhofer.de/AlzheimerOntology#Abeta_40_42_ratio,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Teaching_caregiver_how_to_communicate_and_interact_with_Patients,7,0.0029
http://scai.fraunhofer.de/AlzheimerOntology#Respiridone,2,0.0008
http://scai.fraunhofer.de/NDDUO#non_pharmacotherapy_treatment_context,12,0.0050
http://scai.fraunhofer.de/AlzheimerOntology#natural_product_or_vitamin,6,0.0025
http://scai.fraunhofer.de/NDDUO#Synaptic_vesicles,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Leucocytes,3,0.0012
http://scai.fraunhofer.de/AlzheimerOntology#KIBRA,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#rofecoxib,2,0.0008
http://scai.fraunhofer.de/NDDUO#disorder,21,0.0087
http://scai.fraunhofer.de/AlzheimerOntology#Lewy_body_disease,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Corticobasal_degeneration,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#phospholipase,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#phase_2A,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#phase_2B,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Interneurons,1,0.0004
http://www.ifomis.org/bfo/1.1/span#SpatiotemporalInterval,3,0.0012
http://scai.fraunhofer.de/AlzheimerOntology#Fibrils,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Ganglions,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Cognitive_Tests,13,0.0054
http://scai.fraunhofer.de/NDDUO#Risk_factor,17,0.0071
http://scai.fraunhofer.de/AlzheimerOntology#hepatitis,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Provide_the_patient_with_rest,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Keeping_Tau_from_tangling,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#black,1,0.0004
http://scai.fraunhofer.de/NDDUO#Cellular_and_subcellular_entities,13,0.0054
http://scai.fraunhofer.de/AlzheimerOntology#flavonoid,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Ppp3catm1Jse,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Proteosome,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#CHRNA7,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#CHRNB4,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#spirapril,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#polyphenol,1,0.0004
http://scai.fraunhofer.de/NDDUO#mild_stage_context,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Psen1tm1Bdes,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Aphasia,1,0.0004
http://scai.fraunhofer.de/NDDUO#Neuroinflammation,2,0.0008
http://scai.fraunhofer.de/NDDUO#Animal_species,5,0.0021
http://scai.fraunhofer.de/AlzheimerOntology#CANTAB,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#protein_synthesis,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Experienced_side_effects_from_past_medications,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#neuronal_regeneration,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Beta_Amyloid_control,7,0.0029
http://scai.fraunhofer.de/AlzheimerOntology#NOS2,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#NOS1,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Nonsteroidal_Antiinflamatory_drugs,14,0.0058
http://scai.fraunhofer.de/AlzheimerOntology#MAPK3,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Angiography,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Astroglia_cell_line,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#CD2AP,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Apathy,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#lumiracoxib,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#genetic_depression_scale_score,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#AD7C_test,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#NUPL1,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#lumbar_puncture,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#GSK3_inhibitor_drug_molecule,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#history_of_neoplasma,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Ziprasadone,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Ncln,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#anthocyanin,1,0.0004
http://scai.fraunhofer.de/NDDUO#gene,53,0.0221
http://scai.fraunhofer.de/AlzheimerOntology#cholesterol,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#SILV,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#pravastatin,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Myelin_sheath,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Dysgrosia,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#MRI_consistant_with_the_diagnosis_of_AD,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Cortical_neuron_cell_culture,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Micro_RNA_from_PBMC_cells,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Receptors,9,0.0037
http://scai.fraunhofer.de/AlzheimerOntology#Transfection_cells,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#corticobasal_syndrome,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#desipramine,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Increased_muscle_tone,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Neuronal_firing,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Haloperidol,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Intervention,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#apoptotic_signalling,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Indigestion,2,0.0008
http://scai.fraunhofer.de/NDDUO#Case_cohort_studies,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Psen1tm1Dgf,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Endosomes,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#chlorprothixene,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#loss_of_synapses,2,0.0008
http://scai.fraunhofer.de/NDDUO#Purpose,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#low_density_lipoprotein,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Aspartergic,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Flurazepam,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#glutamate,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Axonal_cone,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Attributable_risks,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Inflammatory_markers,44,0.0183
http://scai.fraunhofer.de/AlzheimerOntology#Side_effects_of_Antipsychotic_drugs,3,0.0012
http://scai.fraunhofer.de/NDDUO#Descriptive_study,7,0.0029
http://scai.fraunhofer.de/AlzheimerOntology#magnetoencephalography,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Abeta_42,4,0.0017
http://scai.fraunhofer.de/AlzheimerOntology#Primate,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Abeta_40,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#protein_misfolding_disorder,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#APEX1,2,0.0008
http://scai.fraunhofer.de/NDDUO#stage_context,5,0.0021
http://scai.fraunhofer.de/AlzheimerOntology#Glycinergic,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#moexipril,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#ApoE_Protein,3,0.0012
http://scai.fraunhofer.de/AlzheimerOntology#vascular_dementia,1,0.0004
http://scai.fraunhofer.de/NDDUO#Foetal_death_rate,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#ratio,2,0.0008
http://scai.fraunhofer.de/NDDUO#Diagnostic_tests,15,0.0062
http://scai.fraunhofer.de/AlzheimerOntology#phosphatidylinositol,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Semegasestat,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#frontotemporal_dementia,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#meclofenamic_acid,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#PiCALm,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Global_Deterioration_scale,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Functional_imaging,1,0.0004
http://scai.fraunhofer.de/NDDUO#Enzymes,2,0.0008
http://www.ifomis.org/bfo/1.1/snap#Object,17,0.0071
http://scai.fraunhofer.de/AlzheimerOntology#Sodium_transport,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Memory_dysfunction,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Other_Risk_factors,7,0.0029
http://scai.fraunhofer.de/NDDUO#exclusion_criterion,13,0.0054
http://scai.fraunhofer.de/AlzheimerOntology#Inability_to_recognize_oneself_or_family,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Spiny_neuron,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Support_and_education_of_family_and_caregiver,5,0.0021
http://scai.fraunhofer.de/AlzheimerOntology#Cevimeline,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#paliperidone,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#MAO_B_inhibitor,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Boston_naming_test,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Populations,3,0.0012
http://scai.fraunhofer.de/AlzheimerOntology#comparative_study,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Physical_state_Examination,8,0.0033
http://scai.fraunhofer.de/AlzheimerOntology#Tumor_Necrosis_Factor_alpha,3,0.0012
http://scai.fraunhofer.de/AlzheimerOntology#neurotoxic,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#aldehyde_dehydrogenase_gene,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Chromosome_1_associated_Alzheimer_s_Disease,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Monocyte_Chemotactic_Protein_1,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Protein_aggregation,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Glutamatergic,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Sea_elegans_gene,3,0.0012
http://scai.fraunhofer.de/AlzheimerOntology#active_infectious_disease,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#etodolac,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Case_control_study,1,0.0004
http://scai.fraunhofer.de/NDDUO#Epidemiological_study_type,4,0.0017
http://scai.fraunhofer.de/AlzheimerOntology#activation_of_the_peroxisome_proliferator_activated_receptor_gamma,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#gastritis,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#neurofibrillary_tangle_formation,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#rasagiline,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#CLU,3,0.0012
http://scai.fraunhofer.de/AlzheimerOntology#TNF,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#modeling_gene_in_animals,6,0.0025
http://scai.fraunhofer.de/AlzheimerOntology#prostaglandin_receptor,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Serotonergic,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Cognitive_decline_is_more_evident_,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Lesion_models,1,0.0004
http://scai.fraunhofer.de/NDDUO#study_design_context,2,0.0008
http://www.ifomis.org/bfo/1.1/snap#Role,9,0.0037
http://scai.fraunhofer.de/AlzheimerOntology#type_2_diabetes_mellitus,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#tolmetin,2,0.0008
http://scai.fraunhofer.de/NDDUO#antidepressant,32,0.0133
http://scai.fraunhofer.de/AlzheimerOntology#Image_based_biomarkers,1,0.0004
http://scai.fraunhofer.de/NDDUO#Thing_that_can_act_as_a_protective_factor,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#blinded_study,1,0.0004
http://scai.fraunhofer.de/NDDUO#Mild,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#neostigmine,2,0.0008
http://scai.fraunhofer.de/NDDUO#In_silico,3,0.0012
http://scai.fraunhofer.de/AlzheimerOntology#Rivastigmine,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#BCL2,2,0.0008
http://scai.fraunhofer.de/NDDUO#Measure_of_central_location,3,0.0012
http://scai.fraunhofer.de/AlzheimerOntology#DAB1,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Psen1tm1Mpm,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#hypothyroidism,1,0.0004
http://scai.fraunhofer.de/NDDUO#Sprouting,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Basophil,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#CNP,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Synaptic_button,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#antiinflammatory_drugs,2,0.0008
http://scai.fraunhofer.de/NDDUO#Nested_case_control_study,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#gender_eligibility,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Infectious_causes,2,0.0008
http://scai.fraunhofer.de/NDDUO#inclusion_criterion,13,0.0054
http://scai.fraunhofer.de/AlzheimerOntology#drug_against_psychosis,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Spine_formation,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Cerebospinal_fluid_Biomarker,10,0.0042
http://scai.fraunhofer.de/AlzheimerOntology#Chromosome_14_assocoated_Alzheimer_s_disease_,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Blood_brain_barrier,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Temporal_lobe,6,0.0025
http://scai.fraunhofer.de/AlzheimerOntology#heme_oxygenase_1,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Side_effects_of_Cholinsetrase_inhibitors,3,0.0012
http://www.ifomis.org/bfo/1.1/span#ConnectedTemporalRegion,6,0.0025
http://scai.fraunhofer.de/AlzheimerOntology#Cholinsetrase_Inhibitors,8,0.0033
http://scai.fraunhofer.de/AlzheimerOntology#alpha_secretase_activity,1,0.0004
http://scai.fraunhofer.de/NDDUO#Epidemiology,6,0.0025
http://scai.fraunhofer.de/AlzheimerOntology#Dyrk1a,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#CPS,1,0.0004
http://www.ifomis.org/bfo/1.1/span#ProcessualEntity,14,0.0058
http://scai.fraunhofer.de/NDDUO#endpoint_classification_design,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Short_portable_mental_status_questionarie,1,0.0004
http://scai.fraunhofer.de/NDDUO#Age_adjusted_mortality_rate,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#imipramine,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Test_for_amyloid_and_amyloid_plaque_presence,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Metrifonate,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#vascular_abnormalities,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Nimodipine,1,0.0004
http://scai.fraunhofer.de/NDDUO#In_vivo,3,0.0012
http://scai.fraunhofer.de/AlzheimerOntology#CREB1,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Galantamine,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#perazine,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#De_phosphorylation,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Flumazenil,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#phosphoinositide,1,0.0004
http://scai.fraunhofer.de/NDDUO#Mortility_rate,12,0.0050
http://scai.fraunhofer.de/AlzheimerOntology#plumbum,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Cumulative_incidence,3,0.0012
http://scai.fraunhofer.de/AlzheimerOntology#CR1,3,0.0012
http://scai.fraunhofer.de/AlzheimerOntology#FRCST,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#study_nurse,2,0.0008
http://scai.fraunhofer.de/NDDUO#secondary_outcome_measure,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#depression,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#cortical_neuron,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#inflammation,4,0.0017
http://scai.fraunhofer.de/AlzheimerOntology#PLG,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#ischemic_lesion,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#CRMP1,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#loratadine,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#EPHA1,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#niactin,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#molecular_entity_used_as_blood_biomarker,3,0.0012
http://scai.fraunhofer.de/AlzheimerOntology#dementia_with_Lewy_bodies,1,0.0004
http://scai.fraunhofer.de/NDDUO#non_pharma_therapy,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Behavioral_Symptoms_of_Moderate_cognitive_decline,5,0.0021
http://scai.fraunhofer.de/AlzheimerOntology#Reduced_tau_phosphorylation,4,0.0017
http://scai.fraunhofer.de/AlzheimerOntology#microtubule_associated_protein,2,0.0008
http://scai.fraunhofer.de/NDDUO#Cohort_study,10,0.0042
http://scai.fraunhofer.de/AlzheimerOntology#Chromosome_19_associated_Alzheimer_s_disease_,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#higher_education,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#mRNA_from_PBMC_cells,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Apptm1Ini,2,0.0008
http://scai.fraunhofer.de/NDDUO#severe_stage_context,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#plant,5,0.0021
http://scai.fraunhofer.de/NDDUO#Applied_epidemiology,3,0.0012
http://scai.fraunhofer.de/NDDUO#Ion_channels,3,0.0012
http://scai.fraunhofer.de/AlzheimerOntology#curcumin_plant,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Amyloid_Beta_42,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#presence_of_neuritic_plaque,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#clinical_dementia_rating,2,0.0008
http://scai.fraunhofer.de/NDDUO#Distribution,3,0.0012
http://scai.fraunhofer.de/NDDUO#Prognostic_study,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Genetic_test,1,0.0004
http://scai.fraunhofer.de/NDDUO#Person,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#ketoprofen,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#APH1A,2,0.0008
http://scai.fraunhofer.de/NDDUO#Mitochondria,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Ependymal_cells,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Cell_cultures,9,0.0037
http://scai.fraunhofer.de/AlzheimerOntology#APH1B,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#ogdc,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Apptm1.1Cep,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Dapsone,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Dalman,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#ergoloid_mesylate,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#synuclein,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Cohort_effect,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#processes_all_cells,14,0.0058
http://scai.fraunhofer.de/AlzheimerOntology#remoxipride,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Neurite_retraction,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Brief_Psychiatric_Rating_Scale,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#vitamin_B12,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#GABAergic,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Sex,1,0.0004
http://scai.fraunhofer.de/NDDUO#spinal_cord_region,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#threenitrotyrosine,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#GPCRs,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Head_trauma,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Axura,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#SHSY5Y,1,0.0004
http://scai.fraunhofer.de/NDDUO#Brain_regions,20,0.0083
http://scai.fraunhofer.de/AlzheimerOntology#Aphraxia,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#open_label_study,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#inflammatory_marker_chemokine,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Calcium_release,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#RAGE_receptor,1,0.0004
http://scai.fraunhofer.de/NDDUO#phase_1,1,0.0004
http://scai.fraunhofer.de/NDDUO#phase_3,1,0.0004
http://scai.fraunhofer.de/NDDUO#phase_2,3,0.0012
http://scai.fraunhofer.de/AlzheimerOntology#folic_acid,1,0.0004
http://scai.fraunhofer.de/NDDUO#phase_4,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Parkinson,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#statin,7,0.0029
http://scai.fraunhofer.de/AlzheimerOntology#Cellular_uptake,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Invloving_patient_in_structured_therapeutic_activities,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#presence_of_amyloid_plaque,3,0.0012
http://scai.fraunhofer.de/AlzheimerOntology#FAD_mutation,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Precuneus,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#amyloid_beta_protein,3,0.0012
http://scai.fraunhofer.de/AlzheimerOntology#central_nervous_system,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#pyridostigmine,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#De_methylation,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#lithium,3,0.0012
http://scai.fraunhofer.de/AlzheimerOntology#Psen1tm1Zhe,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Standardized_incidence_ratio,1,0.0004
http://scai.fraunhofer.de/NDDUO#ex_vivo_context,5,0.0021
http://scai.fraunhofer.de/AlzheimerOntology#Emotional_Fading_,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#thiazolidinedione,3,0.0012
http://scai.fraunhofer.de/NDDUO#Macroglia,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#lateral_temporal_cortex,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#iron,3,0.0012
http://scai.fraunhofer.de/AlzheimerOntology#Spatial_Disorientation_,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#gender_risk_factor,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#mitochondrial_dysfunctioning,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#vitamin_molecule,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Simplify_routines,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#senile_dementia,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#advanced_glycation_end_product,2,0.0008
http://scai.fraunhofer.de/NDDUO#disease_cause,6,0.0025
http://scai.fraunhofer.de/NDDUO#Evaluation,5,0.0021
http://scai.fraunhofer.de/AlzheimerOntology#n_acetyl_d_glucosamine,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#brain,1,0.0004
http://www.ifomis.org/bfo/1.1/snap#ObjectAggregate,6,0.0025
http://scai.fraunhofer.de/AlzheimerOntology#endothelial_activation,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#mini_mental_state_examination_score,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#functional_MRI,3,0.0012
http://scai.fraunhofer.de/AlzheimerOntology#Primary_neuronal_cell_culture,3,0.0012
http://scai.fraunhofer.de/AlzheimerOntology#vacular_inflammation,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#carbonyl,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#E1F3A,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Acetyl_L_Carnatine,2,0.0008
http://scai.fraunhofer.de/NDDUO#Study_arm,8,0.0033
http://scai.fraunhofer.de/AlzheimerOntology#GRN,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#PLP1,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#baseline_state,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#TARDBP,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Microglial_activation,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#lewy_body,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#active_vaccination,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Symptoms_of_MILD_AD,8,0.0033
http://scai.fraunhofer.de/AlzheimerOntology#Exocytosis,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Urine,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Voltage_gated,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Early_Signs,6,0.0025
http://scai.fraunhofer.de/AlzheimerOntology#study_subject,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#drug_abuse,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#TGM2,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#PLAU,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#PLAT,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Early_onset_Alzheimer_s_Disease__,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#glutamate_modulating_drug,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#chromogranin,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#NR3C1,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#inflammatory_risk_factor,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#ambenonium,2,0.0008
http://scai.fraunhofer.de/NDDUO#nerological_examination,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#RAGE,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#cholesteryl_ester_transfer_protein,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#acetylcholine,1,0.0004
http://scai.fraunhofer.de/NDDUO#beta_amyloid_control_context,6,0.0025
http://scai.fraunhofer.de/AlzheimerOntology#Pyramidal_neuron,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#hippocampal_formation_region,2,0.0008
http://scai.fraunhofer.de/NDDUO#Rodents,4,0.0017
http://scai.fraunhofer.de/NDDUO#Pharmacotherapy,4,0.0017
http://scai.fraunhofer.de/AlzheimerOntology#Limit_stimulation,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#clusterin,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#beta_secretase_activity,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#ZNF224,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#glutathione,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Pfeiffer_s_short_portable_mental_status_questionaire,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Flurizan,1,0.0004
http://www.ifomis.org/bfo/1.1/snap#ThreeDimensionalRegion,5,0.0021
http://scai.fraunhofer.de/AlzheimerOntology#Microglia_related_to_primary_glial_cell_culture,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#CALHM1,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#PDHA1,2,0.0008
http://scai.fraunhofer.de/NDDUO#male,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Symptoms_of_severe_AD,10,0.0042
http://scai.fraunhofer.de/AlzheimerOntology#GSK3_inhibitor,3,0.0012
http://scai.fraunhofer.de/AlzheimerOntology#corticotrophin_releasing_hormone,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Increased_sleeping,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#caregiver_eligibility,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Splicing_variants,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#dorsal_midbrain,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#presenilin,3,0.0012
http://scai.fraunhofer.de/AlzheimerOntology#Longitudinal_study,1,0.0004
http://www.w3.org/2002/07/owl#Thing,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#neurofibrillary_tangle,3,0.0012
http://scai.fraunhofer.de/NDDUO#Morbidity,4,0.0017
http://scai.fraunhofer.de/NDDUO#Diagnostic_Procedures,10,0.0042
http://scai.fraunhofer.de/AlzheimerOntology#CA1,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Medium_spiny_neuron,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#galanin,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Granule_cells,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#MS4A4,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Decrease_in_planning_or_organizational_skills_,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#sporadic_Alzheimer,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#VEGF,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#brain_tissue,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Hazard_ratio,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Constipation,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#bioluminescence_imaging,1,0.0004
http://www.ifomis.org/bfo/1.1/span#ScatteredSpatiotemporalRegion,3,0.0012
http://scai.fraunhofer.de/AlzheimerOntology#Alzheimer_risk_factor_gene,150,0.0625
http://scai.fraunhofer.de/NDDUO#Clinical_assesment,7,0.0029
http://scai.fraunhofer.de/AlzheimerOntology#Glutamate_toxicity,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Maintaining_overall_health_through_regular_medical_care__diet__and_exercise,2,0.0008
http://www.ifomis.org/bfo/1.1/span#ScatteredTemporalRegion,3,0.0012
http://scai.fraunhofer.de/AlzheimerOntology#mass_spectrometry,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#sulpiride,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#posterior_temporal_lobe,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Dimebolin,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#chemokine,20,0.0083
http://scai.fraunhofer.de/AlzheimerOntology#drug_for_moderate_to_severe_alzheimer,6,0.0025
http://scai.fraunhofer.de/AlzheimerOntology#cytokine,18,0.0075
http://scai.fraunhofer.de/NDDUO#Molecular_entities,89,0.0371
http://scai.fraunhofer.de/AlzheimerOntology#dose_ranging_study,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Ubqln1,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Clorazepate,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Erythrocyte_sedimentation_rate,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#amyloid_fibril,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#secretase_inhibitor,4,0.0017
http://scai.fraunhofer.de/NDDUO#primary_outcome_measure,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Cognitive_behavioral_management,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#enzyme,22,0.0092
http://scai.fraunhofer.de/AlzheimerOntology#Behavioral_therapies,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Microvascular_Markers,4,0.0017
http://scai.fraunhofer.de/AlzheimerOntology#synaptic_dysfunctioning,3,0.0012
http://scai.fraunhofer.de/AlzheimerOntology#tauopathy,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Incidence_density_ratio,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Psen1tm1Vln,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#cellular_process_endothelial_site,4,0.0017
http://scai.fraunhofer.de/AlzheimerOntology#processes_related_to_neurons,20,0.0083
http://scai.fraunhofer.de/AlzheimerOntology#lipid_peroxidation,1,0.0004
http://scai.fraunhofer.de/NDDUO#Concurrent_cohort_study,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Transcription_factors,3,0.0012
http://scai.fraunhofer.de/AlzheimerOntology#Parallel_fibres,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Analysis_of_cohort_studies,5,0.0021
http://scai.fraunhofer.de/AlzheimerOntology#deprenyl,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Mementine,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Case_fatality_rate,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Purkinje_cells,1,0.0004
http://scai.fraunhofer.de/NDDUO#pathology_context,18,0.0075
http://scai.fraunhofer.de/AlzheimerOntology#Studying_medication_history,3,0.0012
http://scai.fraunhofer.de/AlzheimerOntology#Folstein_minimental_test,1,0.0004
http://scai.fraunhofer.de/NDDUO#Prevalence_rate,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#TP53,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#unawareness_of_deficits,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Current_chronic_conditions,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#VPS26A,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#metal_chelation,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#amoxapine,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Computerized_tomography,3,0.0012
http://scai.fraunhofer.de/NDDUO#female,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Clock_drawn_test,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Opioidergic_neuron,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Pre_synaptic,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#APOE,3,0.0012
http://scai.fraunhofer.de/AlzheimerOntology#Brain_slices,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Other_Drugs,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Dysphasia,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#melatonin,1,0.0004
http://scai.fraunhofer.de/NDDUO#procedures_using_biomarkers_context,36,0.0150
http://scai.fraunhofer.de/AlzheimerOntology#clomipramine,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Micro_RNA,3,0.0012
http://www.ifomis.org/bfo/1.1/snap#TwoDimensionalRegion,5,0.0021
http://scai.fraunhofer.de/AlzheimerOntology#dyslipidemia,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Synaptic_spine,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#single_masked_study,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#calcium,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#IL1A,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#antipsychotic_side_effect,5,0.0021
http://scai.fraunhofer.de/AlzheimerOntology#lavender,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#PSEN2_test,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#GAB2,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#SYP,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#moclobemide,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Alzheimer_s_Disease_Assessment_Scale,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#PCK1,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Ginkgo_biloba_plant,1,0.0004
http://scai.fraunhofer.de/NDDUO#Measure_of_dispersion,3,0.0012
http://scai.fraunhofer.de/AlzheimerOntology#Autophagy,1,0.0004
http://scai.fraunhofer.de/NDDUO#Vertebrate,4,0.0017
http://scai.fraunhofer.de/AlzheimerOntology#minaprine,2,0.0008
http://scai.fraunhofer.de/NDDUO#family_based_study,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#HSPA1B,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#beta_amyloid_pathway_function,5,0.0021
http://scai.fraunhofer.de/AlzheimerOntology#Mood_Evaluation,3,0.0012
http://scai.fraunhofer.de/AlzheimerOntology#Skin_Hives,2,0.0008
http://scai.fraunhofer.de/NDDUO#pathogenesis_context,20,0.0083
http://scai.fraunhofer.de/AlzheimerOntology#white,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#pai1,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#N_methyl_D_aspartate_receptor,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Transgeneic_cells,1,0.0004
http://scai.fraunhofer.de/NDDUO#Life_time_prevalence,2,0.0008
http://scai.fraunhofer.de/NDDUO#Regulation_of_gene_expression,4,0.0017
http://scai.fraunhofer.de/AlzheimerOntology#polymer,1,0.0004
http://scai.fraunhofer.de/NDDUO#epidemiology_context,15,0.0062
http://scai.fraunhofer.de/AlzheimerOntology#Heart_disease,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#malondialdehyde,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#cilazapril,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Personality_changes,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#kidney_function_screening,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#GABAergic_neuron,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#sertraline,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#KPNA1,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#KPNA5,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#NOS1_enzyme,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#moving_average_plot,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Misplacing_important_objects_with_increasing_frequency_,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#fluvastatin,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Blood_Biomarker,6,0.0025
http://scai.fraunhofer.de/AlzheimerOntology#nabumetone,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Increased_frequency_of_bowel_movement,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#APEH,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Prefrontal_cortex,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Multiple_System_atrophy,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#posterior_cingulate_cortex,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Weight_loss,1,0.0004
http://scai.fraunhofer.de/NDDUO#mechanism_of_action_context,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#risperidone,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Swelling,1,0.0004
http://scai.fraunhofer.de/NDDUO#surgical_context,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Monocyte_Chemotactic_Protein,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#triflupromazine,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#blonanserin,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Vomiting,3,0.0012
http://www.ifomis.org/bfo/1.1/span#TemporalInstant,3,0.0012
http://scai.fraunhofer.de/AlzheimerOntology#Chromosome_12_associated_Alzheimer_s_Disease,2,0.0008
http://scai.fraunhofer.de/NDDUO#cellular_context,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Filaments,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Frontotemporal_Dementia,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#antibody,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#diclofenac,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#FTL,2,0.0008
http://scai.fraunhofer.de/NDDUO#Protective_factors,12,0.0050
http://scai.fraunhofer.de/AlzheimerOntology#Zebra_fish_gene,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#ACE_inhibitor,15,0.0062
http://scai.fraunhofer.de/AlzheimerOntology#Ratio_phospho_tau_abeta_42_test,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Nitrosylation,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#BACE_1_activity_test,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#occipital_cortex,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#naproxen,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#cytochrome_C_oxidase,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Chromosome_10_associated_Alzheimer_s_Disease,2,0.0008
http://scai.fraunhofer.de/NDDUO#diagnosis_context,20,0.0083
http://scai.fraunhofer.de/NDDUO#masking_design,1,0.0004
http://scai.fraunhofer.de/NDDUO#drug_side_effect,5,0.0021
http://scai.fraunhofer.de/AlzheimerOntology#t_tau_Amyloid_beta_42,3,0.0012
http://scai.fraunhofer.de/AlzheimerOntology#sirtuin,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#lisinopril,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Myelinisation,3,0.0012
http://scai.fraunhofer.de/NDDUO#statistical_context,8,0.0033
http://scai.fraunhofer.de/AlzheimerOntology#Oxidative_stress,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Stomach_pain,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Plautm1Mlg,2,0.0008
http://www.ifomis.org/bfo/1.1/span#ProcessAggregate,6,0.0025
http://scai.fraunhofer.de/AlzheimerOntology#Clock_draw_test,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#single_blind_study,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#dorsolateral_prefrontal_cortex,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Synaptic_release,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#NRG3,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#NRG1,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#pregnant_woman,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#FoxO,1,0.0004
http://scai.fraunhofer.de/NDDUO#Trend,3,0.0012
http://scai.fraunhofer.de/NDDUO#Voltage_gated,1,0.0004
http://scai.fraunhofer.de/NDDUO#Age_specific_mortality_rate,1,0.0004
http://scai.fraunhofer.de/NDDUO#Measurement_scale,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Apptm1Dbo,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Caffeine_consumption,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#_The_Consortium_to_Establish_a_Registry_for_Alzheimer_s_Disease,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#secretase,4,0.0017
http://www.ifomis.org/bfo/1.1/snap#IndependentContinuant,8,0.0033
http://scai.fraunhofer.de/AlzheimerOntology#Mini_mental_status_examination,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Rosovastatin,3,0.0012
http://scai.fraunhofer.de/AlzheimerOntology#Electrolyte_test,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Headache,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Spingomyleins,3,0.0012
http://scai.fraunhofer.de/AlzheimerOntology#cognitive_reserve_questionnaire,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Brief_Screening_Test,7,0.0029
http://scai.fraunhofer.de/AlzheimerOntology#macrophage_colony_stimulating_factor,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#TNFRSF21,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#KPNB1,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#SST,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Mitochondria,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#control_subject,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#TRAIL_R3,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#neuroimaging,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#locus_ceruleus,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Family_History,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#non_human_primate,1,0.0004
http://scai.fraunhofer.de/NDDUO#Second_generation_migrant,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Cholestrol_reducing_drugs,5,0.0021
http://scai.fraunhofer.de/NDDUO#Cumulative_death_rate,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Curcumin,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#FYN,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#drug_used_in_treatment,148,0.0616
http://scai.fraunhofer.de/AlzheimerOntology#Pataients_may_experience_Vomiting,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#fenoprofen,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Temazepam,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#eotaxin3,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#BAX,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#decursin,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#atrophy,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#PiB_PET,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Astroglia_cell_line_related_to_non_clinical_entity,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Pharmacological_model,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#DPYSL3,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#DPYSL2,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#AKT1,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#DPYSL5,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#IL8RB,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Blood_Pressure_checkup,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Brain_Imaging,8,0.0033
http://scai.fraunhofer.de/AlzheimerOntology#benazepril,2,0.0008
http://scai.fraunhofer.de/NDDUO#model,4,0.0017
http://scai.fraunhofer.de/AlzheimerOntology#cerebral_cortex,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Nos2tm1Lau,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#wine,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#immunotherapy,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#galanin_receptor,4,0.0017
http://scai.fraunhofer.de/AlzheimerOntology#procedures_using_biomarkers,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Post_synaptic,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Prior_Injuries_or_surgeries,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#behavioral_symptom,1,0.0004
http://scai.fraunhofer.de/NDDUO#Severe,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Allergies,1,0.0004
http://scai.fraunhofer.de/NDDUO#Cluster,3,0.0012
http://scai.fraunhofer.de/AlzheimerOntology#Golgi,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#age_risk_factor,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#GalR1,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#GalR2,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Homocystein,4,0.0017
http://scai.fraunhofer.de/AlzheimerOntology#GalR3,1,0.0004
http://scai.fraunhofer.de/NDDUO#non_pharmacotherapy_procedure,4,0.0017
http://scai.fraunhofer.de/AlzheimerOntology#Regulation_of_transcription,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Synaptic_transport,1,0.0004
http://scai.fraunhofer.de/NDDUO#outcome_context,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Dimerization,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#JUN,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Mann_Whitney_test,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#copper,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#astrocyte_activation,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Tacrine,3,0.0012
http://scai.fraunhofer.de/AlzheimerOntology#inhibition_of_gamma_secretase,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#off_label_use_study_arm,1,0.0004
http://scai.fraunhofer.de/NDDUO#Neurodegeneration,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#tenoxicam,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#study_investigator,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Closed_populations_,1,0.0004
http://scai.fraunhofer.de/NDDUO#Annual_prevalence,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#senile_plaque,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Cambridge_neuropsychological_Test_automated_Battery,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Neuro2A,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Lymphocyte,3,0.0012
http://scai.fraunhofer.de/AlzheimerOntology#Skin_infections,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#metabolic_disease,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#VAMP2,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Gas1,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Increased_memory_loss_and_confusion,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#c_Jun_N_terminal_kinase,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#MIP1_beta,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#thalamus,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#cellular_processes_microglia_site,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#amyloid_beta_deposition,3,0.0012
http://scai.fraunhofer.de/AlzheimerOntology#drug_for_mild_to_moderate_alzheimer,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Education_through_specialized_programmes,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#pimozide,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#intervention_study,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#vascular,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#lipid,4,0.0017
http://scai.fraunhofer.de/AlzheimerOntology#Cholinergic,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#De_myelination,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Neuropsychological_test,8,0.0033
http://scai.fraunhofer.de/AlzheimerOntology#Cumulative_incidence_rate,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#E1F2B3,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Pericytes,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Microglia_activation,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#thing_that_acts_as_a_genetic_biomarker,3,0.0012
http://scai.fraunhofer.de/AlzheimerOntology#CTNNB1,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#E1F2B2,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#clozapine,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#E1F2B1,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Varenicline,1,0.0004
http://scai.fraunhofer.de/NDDUO#intervention_context,2,0.0008
http://scai.fraunhofer.de/NDDUO#Age_standardized_mortality_rate,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#E1F2B5,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#E1F2B4,2,0.0008
http://scai.fraunhofer.de/NDDUO#equipment,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Unlinked_familial_Alzheimer_s_Disaease,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Vascular_cell_adhesion_molecule-1,3,0.0012
http://scai.fraunhofer.de/AlzheimerOntology#chi_square,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#CXCR1,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#SIRT6,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#SIRT7,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#CXCR5,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#SIRT4,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#acetylcholinesterase,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#SIRT5,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#CXCR4,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Spends_a_lot_of_time_observing,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#CXCR3,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#SIRT2,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#SIRT3,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#CXCR2,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#phosphatidylcholine,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#SIRT1,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#neocortex,5,0.0021
http://www.ifomis.org/bfo/1.1/span#Occurrent,7,0.0029
http://scai.fraunhofer.de/AlzheimerOntology#PSEN1_test,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#DIEEPS,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Non_GPCRs,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Cooper_and_zinc_modulator_drug_molecule,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Post_ganglionic_cells,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Delusions_and_paranoia,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#CHARNB2,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Memory_problem_starts,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Lung_Checkup,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#glial_fibrillary_acidic_protein,2,0.0008
http://scai.fraunhofer.de/NDDUO#Neurons,19,0.0079
http://scai.fraunhofer.de/AlzheimerOntology#Ion_channels,3,0.0012
http://scai.fraunhofer.de/AlzheimerOntology#FAT,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Cingulate_cortex,3,0.0012
http://scai.fraunhofer.de/AlzheimerOntology#corpus_geniculatum_laterale,1,0.0004
http://scai.fraunhofer.de/NDDUO#Death_to_case_ratio,3,0.0012
http://scai.fraunhofer.de/NDDUO#Transcription_factors,1,0.0004
http://www.ifomis.org/bfo/1.1/snap#DependentContinuant,12,0.0050
http://scai.fraunhofer.de/NDDUO#Transpoters,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Studying_medical_history,4,0.0017
http://scai.fraunhofer.de/AlzheimerOntology#Oligodendrocytes,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#entity_used_as_an_inflammatory_marker,5,0.0021
http://scai.fraunhofer.de/NDDUO#outcome_measure,5,0.0021
http://scai.fraunhofer.de/AlzheimerOntology#ATXN1,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Ebixa,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#CSE1L,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#wild_type_AD,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Moderate_cognitive_Decline,1,0.0004
http://scai.fraunhofer.de/NDDUO#Zebrafish,11,0.0046
http://scai.fraunhofer.de/AlzheimerOntology#Glutamatergic_neuron,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#fluvoxamine,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Realtive_risk,1,0.0004
http://www.ifomis.org/bfo/1.1/span#ProcessBoundary,6,0.0025
http://scai.fraunhofer.de/NDDUO#Morbidity_survey,1,0.0004
http://scai.fraunhofer.de/NDDUO#secondary_measure_context,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#FDG,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Interleukin_12,3,0.0012
http://scai.fraunhofer.de/AlzheimerOntology#Interleukin_10,3,0.0012
http://scai.fraunhofer.de/AlzheimerOntology#NTS,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Interleukin_16,3,0.0012
http://www.ifomis.org/bfo/1.1/snap#FiatObjectPart,6,0.0025
http://scai.fraunhofer.de/AlzheimerOntology#Targeted_gene,3,0.0012
http://scai.fraunhofer.de/AlzheimerOntology#NOTCH1,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#randomized_study,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#aripiprazole,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Hippocampus,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Mood_and_personality_changes,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#valdecoxib,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#AGER,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Mitochondria_transport,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#cell_signalling,3,0.0012
http://scai.fraunhofer.de/AlzheimerOntology#Difficulty_swallowing,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Necrosis,1,0.0004
http://scai.fraunhofer.de/NDDUO#disease,1,0.0004
http://scai.fraunhofer.de/NDDUO#clinical_context,9,0.0037
http://scai.fraunhofer.de/AlzheimerOntology#alcohol_abuse,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Interleukin_18,3,0.0012
http://scai.fraunhofer.de/AlzheimerOntology#omega3_fatty_acids,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Tranxene,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#double_blinded_study,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Psen1tm1Jzt,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Use_labels_as_a_reminder,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#sulindac,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Simple_Word_Test,5,0.0021
http://scai.fraunhofer.de/AlzheimerOntology#Phospho_tau_test,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Microglia_activation_related_to_PET,1,0.0004
http://www.ifomis.org/bfo/1.1/snap#Quality,23,0.0096
http://www.ifomis.org/bfo/1.1/snap#SpecificallyDependentContinuant,9,0.0037
http://www.ifomis.org/bfo/1.1/span#SpatiotemporalRegion,7,0.0029
http://scai.fraunhofer.de/AlzheimerOntology#geriatric_depression_scale,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#expression_of_iNOS,1,0.0004
http://scai.fraunhofer.de/NDDUO#Correlation_study,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Apoptosis,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Poor_judgment,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Late_Onset_Alzheimer_s_Disease,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#DSM_IV,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#control_trials_study_arm,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#FCSRT_result,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Thyroid_Functioning,1,0.0004
http://scai.fraunhofer.de/NDDUO#Surveillance,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#phase_0,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Initial_causes,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Ligand_gated,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#obesity,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Genetics,136,0.0566
http://scai.fraunhofer.de/AlzheimerOntology#escitalopram,2,0.0008
http://scai.fraunhofer.de/NDDUO#genetic_cause_context,8,0.0033
http://scai.fraunhofer.de/AlzheimerOntology#Memory_orientation_screening_test,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Alpha_secretase,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Vitamin_B12_test,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Pyramidal_cortex,1,0.0004
http://scai.fraunhofer.de/NDDUO#Disease_rate_at_autopsy,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Mental_Status_Exam,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#age_eligibility,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Use_calm__positive_statements,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Incidence_rate,5,0.0021
http://scai.fraunhofer.de/AlzheimerOntology#Basket_cells,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#substantia_nigra_region,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Re_myelination,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Membranes,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Behavioral_Symptoms_of_Mild_cognitive_impairment,4,0.0017
http://scai.fraunhofer.de/AlzheimerOntology#Rosiglitazone,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#doxepin,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Neuropsychiatric_inventory,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Alexy,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#PBT2,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#neurofilament_test,1,0.0004
http://scai.fraunhofer.de/NDDUO#descriptive_epidemiology_context,4,0.0017
http://scai.fraunhofer.de/AlzheimerOntology#Circulating_Proteins,5,0.0021
http://scai.fraunhofer.de/AlzheimerOntology#glucocorticoid,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#glucose_utilization,1,0.0004
http://scai.fraunhofer.de/NDDUO#Prevalence,3,0.0012
http://scai.fraunhofer.de/AlzheimerOntology#Ventricles,1,0.0004
http://scai.fraunhofer.de/NDDUO#allocation_design,1,0.0004
http://scai.fraunhofer.de/NDDUO#Race_specific_mortality_rate,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Downregulation,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#cerebrospinal_fluid,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Magnetic_resonance_imaging,4,0.0017
http://scai.fraunhofer.de/AlzheimerOntology#galantamine,2,0.0008
http://scai.fraunhofer.de/NDDUO#Recruitment_crieteria,4,0.0017
http://scai.fraunhofer.de/AlzheimerOntology#Glia_glia_interaction,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#unstable_illness,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Clutm1Jakh,2,0.0008
http://www.ifomis.org/bfo/1.1/snap#RealizableEntity,6,0.0025
http://scai.fraunhofer.de/AlzheimerOntology#APP,6,0.0025
http://scai.fraunhofer.de/AlzheimerOntology#Endoplasmic_reticulam,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Chromosome_21_associated_Alzheimer_s_disease_,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#arylquinone,1,0.0004
http://www.ifomis.org/bfo/1.1/snap#Site,7,0.0029
http://scai.fraunhofer.de/AlzheimerOntology#mitochondrial_change,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#ITM2B,2,0.0008
http://scai.fraunhofer.de/NDDUO#Frequency_measure,3,0.0012
http://scai.fraunhofer.de/NDDUO#Molecular_and_cellular_mechanism,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#antidementia_agent,4,0.0017
http://scai.fraunhofer.de/AlzheimerOntology#interleukin_3,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#paroxetine,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Mossy_fibres,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#fosinopril,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Genetic_Biomarkers,12,0.0050
http://scai.fraunhofer.de/AlzheimerOntology#Action_potential,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#T-Lymphocyte,1,0.0004
http://scai.fraunhofer.de/NDDUO#Genetic_causes,3,0.0012
http://scai.fraunhofer.de/NDDUO#infectious_cause_context,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Abeta_1-40_test,1,0.0004
http://scai.fraunhofer.de/NDDUO#Study_design,6,0.0025
http://scai.fraunhofer.de/AlzheimerOntology#cerebral_hemisphere,1,0.0004
http://scai.fraunhofer.de/NDDUO#Case_study,1,0.0004
http://scai.fraunhofer.de/NDDUO#primary_measure_context,1,0.0004
http://www.ifomis.org/bfo/1.1/snap#GenericallyDependentContinuant,27,0.0112
http://scai.fraunhofer.de/NDDUO#Measure_of_disease_ocurrence,4,0.0017
http://scai.fraunhofer.de/AlzheimerOntology#control_group_study_arm,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#methotrimeprazine,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Saltatory_conduction,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Gama_secretase,2,0.0008
http://scai.fraunhofer.de/NDDUO#measure_of_disease_occurrence_context,12,0.0050
http://scai.fraunhofer.de/AlzheimerOntology#phagocytosis,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Axon_collapse,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#_Mild_Dizziness,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Organotypic_cultures,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#ASL,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#arterial_hypertension,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#CDK5R1,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Lack_of_control_of_bowel_and_bladder,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Cholinergic_neuron,1,0.0004
http://scai.fraunhofer.de/NDDUO#applied_epidemiology_context,4,0.0017
http://scai.fraunhofer.de/AlzheimerOntology#GYS1,2,0.0008
http://scai.fraunhofer.de/NDDUO#Non_clinical,5,0.0021
http://scai.fraunhofer.de/AlzheimerOntology#Blessed_Information_memory_concentration_test,1,0.0004
http://www.ifomis.org/bfo/1.1/snap#MaterialEntity,32,0.0133
http://scai.fraunhofer.de/AlzheimerOntology#enalapril,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Mitophagia,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#mesoridazine,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Psen2tm1Ber,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#fcMRI,1,0.0004
http://scai.fraunhofer.de/NDDUO#Anatomical,8,0.0033
http://scai.fraunhofer.de/AlzheimerOntology#Agranulocyte,3,0.0012
http://scai.fraunhofer.de/AlzheimerOntology#MAPT,6,0.0025
http://scai.fraunhofer.de/NDDUO#molecular_and_cellular_mechanism_context,21,0.0087
http://scai.fraunhofer.de/AlzheimerOntology#ramipril,2,0.0008
http://scai.fraunhofer.de/NDDUO#Pathology,3,0.0012
http://scai.fraunhofer.de/NDDUO#Cross_sectional_survey,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#basal_ganglia_region,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Glucose_transport,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#primary_purpose_design,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#drug_for_ACE_inhibition,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Immunization_statergies,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Problems_coping_with_new_situations,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#prochlorperazine,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Other_Biomarkers,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Frontal_lobe,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Chest_pain,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#trazodone,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#phosphatidylethanolamine,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Interleukin_6,3,0.0012
http://scai.fraunhofer.de/AlzheimerOntology#Interleukin_8,3,0.0012
http://scai.fraunhofer.de/AlzheimerOntology#ketorolac,2,0.0008
http://scai.fraunhofer.de/NDDUO#Cell_death,3,0.0012
http://scai.fraunhofer.de/AlzheimerOntology#Orientation_loss,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#macrophages,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#outcome_assessor,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#anxiety,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#trimipramine,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Neuroblastoma_cell_lines,4,0.0017
http://scai.fraunhofer.de/AlzheimerOntology#Nausea,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Myloperoxidase,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Psen1tm1Shn,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#Interleukin_1,3,0.0012
http://scai.fraunhofer.de/AlzheimerOntology#Interleukin_4,3,0.0012
http://scai.fraunhofer.de/AlzheimerOntology#Spine_retraction,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#Cell_body,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#MIP1_alpha,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#insulin_resistance,2,0.0008
http://scai.fraunhofer.de/AlzheimerOntology#California_Verbal_learning_test,1,0.0004
http://scai.fraunhofer.de/AlzheimerOntology#NPY,2,0.0008
http://scai.fraunhofer.de/NDDUO#pharmacotherapy_treatment_context,15,0.0062
http://scai.fraunhofer.de/AlzheimerOntology#razadyne,2,0.0008
